AcouSort AB

ST:ACOU Sweden Biotechnology
Market Cap
$6.04 Million
Skr67.72 Million SEK
Market Cap Rank
#31398 Global
#468 in Sweden
Share Price
Skr3.20
Change (1 day)
+9.22%
52-Week Range
Skr2.13 - Skr4.13
All Time High
Skr31.61
About

AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC … Read more

AcouSort AB (ACOU) - Total Liabilities

Latest total liabilities as of September 2025: Skr3.21 Million SEK

Based on the latest financial reports, AcouSort AB (ACOU) has total liabilities worth Skr3.21 Million SEK as of September 2025.

Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.

AcouSort AB - Total Liabilities Trend (2013–2024)

This chart illustrates how AcouSort AB's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.

AcouSort AB Competitors by Total Liabilities

The table below lists competitors of AcouSort AB ranked by their total liabilities.

Liability Composition Analysis (2013–2024)

This chart breaks down AcouSort AB's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 5.33 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 0.17 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.15 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how AcouSort AB's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for AcouSort AB (2013–2024)

The table below shows the annual total liabilities of AcouSort AB from 2013 to 2024.

Year Total Liabilities Change
2024-12-31 Skr3.86 Million -62.80%
2023-12-31 Skr10.38 Million -53.96%
2022-12-31 Skr22.54 Million +537.14%
2021-12-31 Skr3.54 Million -1.15%
2020-12-31 Skr3.58 Million +69.38%
2019-12-31 Skr2.11 Million +13.60%
2018-12-31 Skr1.86 Million +74.81%
2017-12-31 Skr1.06 Million -48.94%
2016-12-31 Skr2.08 Million +1044.60%
2015-12-31 Skr182.07K -66.51%
2014-12-31 Skr543.60K -74.88%
2013-12-31 Skr2.16 Million --